Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Clinical trial NCT04909255 · UNKNOWN
Trial details
- NCT number
- NCT04909255
- Sponsor
- China Medical University Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2022-08-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.